Emergent Biosolutions Inc
EBS
Get informed when a big investor buys or sells
+ FollowMarket Cap$327.12M
Close$
$-7.39
218.6% downside
Current Fair Value
218.6% downsideOvervalued by 218.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $327.12 Million |
|---|---|
| Enterprise Value | $784.22 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.98 |
| Beta | 2.29 |
| Outstanding Shares | 51,600,000 |
Return
| Return on Equity | -53.78% |
|---|---|
| Return on Assets | -16.44% |
| Return on Invested Capital | -3.05% |
Valuation & Multiples
| P/E Ratio | -1.85 |
|---|---|
| PEG | -0.13 |
| Price to Sales | 0.45 |
| Price to Book Ratio | 1.04 |
| Enterprise Value to Revenue | 1.02 |
| Enterprise Value to EBIT | -25.88 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.76 |
| Debt to Equity | 1.75 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
$177.50 M
Average shareholder expectationNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
$-0.41
Average shareholder expectationRevenue Estimate
$209.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 33.77% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.16%▼ 88.58% |
|---|---|
| Total Invested | $539,888▼ 99.86% |
| Investors Holding | 13▼ 188.00% |
ESG Score
No data
About Emergent Biosolutions Inc
900 employees
CEO: Robert Kramer Emergent BioSolutions Inc. is a life sciences enterprise dedicated to developing and delivering solutions for preparing for and responding to diverse public health threats (PHTs) in the United States. Its mission involves countering unfo...